Smarter, safer, and more cost-effective treatment methods.

Aurealis Pharma, a biopharmaceutical company based in Kuopio, Finland and Basel, Switzerland, has developed an effective, safe and economical treatment method that greatly improves the quality of life for chronic inflammation and cancer sufferers.

  • Aurealis Pharma to Discuss AUP-16 Clinical Development at the 27th European Wound Managament Association Annual Meeting on May 3-5th 2017 in Amsterdam

News archive »


Aurealis Pharma

Embracing science. Enhancing lives.

Site by Mainostoimisto Ad Kiivi